We are live on ! Find out more
MJP

Michael J. Puzo Portfolio holdings

AUM $343M
1-Year Est. Return 18.42%
This Fund
S&P 500
This Quarter Est. Return
-0.79%
1 Year Est. Return
+18.42%
3 Year Est. Return
+60.27%
5 Year Est. Return
+82.68%
10 Year Est. Return
+283.93%
AUM
$235M
AUM Growth
-$7.89M
Cap. Flow
-$2.87M
Cap. Flow %
-1.22%
Top 10 Hldgs %
38.2%
Holding
80
New
1
Increased
20
Reduced
47
Closed
1

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$702K
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$490K
3
FTV icon
Fortive
FTV
+$310K
4
AAPL icon
Apple
AAPL
+$298K
5
RTX icon
RTX Corp
RTX
+$290K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$701K
2
JNJ icon
Johnson & Johnson
JNJ
+$622K
3
GE icon
GE Aerospace
GE
+$556K
4
MSFT icon
Microsoft
MSFT
+$515K
5
INTC icon
Intel
INTC
+$362K

Sector Composition

Rank Sector Weight
1 Technology 22.99%
2 Healthcare 22.93%
3 Industrials 14.71%
4 Financials 10.28%
5 Consumer Staples 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XYL icon
26
Xylem
XYL
$28.5B
$3.09M 1.32%
40,210
-1,560
-4% -$115K
ORCL icon
27
Oracle
ORCL
$331B
$3M 1.28%
65,676
-5,850
-8% -$291K
CVX icon
28
Chevron
CVX
$388B
$2.85M 1.21%
25,022
+1,900
+8% +$227K
PEP icon
29
PepsiCo
PEP
$186B
$2.51M 1.07%
22,986
+200
+0.9% +$22.7K
EOG icon
30
EOG Resources
EOG
$78B
$2.44M 1.04%
23,185
+1,610
+7% +$174K
ILMN icon
31
Illumina
ILMN
$29.4B
$2.12M 0.9%
9,190
+719
+8% +$165K
ABBV icon
32
AbbVie
ABBV
$458B
$1.76M 0.75%
18,576
-550
-3% -$60.4K
MRK icon
33
Merck
MRK
$324B
$1.67M 0.71%
32,176
-524
-2% -$28.3K
SJM icon
34
J.M. Smucker
SJM
$12.6B
$1.58M 0.67%
12,737
+650
+5% +$81.2K
EMR icon
35
Emerson Electric
EMR
$82.9B
$1.42M 0.6%
20,726
– –
ESBA icon
36
Empire State Realty Series ES
ESBA
$1.49B
$1.38M 0.59%
82,573
-4,000
-5% -$72.1K
GILD icon
37
Gilead Sciences
GILD
$161B
$1.34M 0.57%
17,796
-100
-0.6% -$7.95K
FTV icon
38
Fortive
FTV
$19B
$1.33M 0.57%
27,156
+6,509
+32% +$310K
MKC icon
39
McCormick & Company Non-Voting
MKC
$13.4B
$1.25M 0.53%
23,400
+150
+0.6% +$7.89K
V icon
40
Visa
V
$677B
$1.24M 0.53%
10,380
-900
-8% -$109K
BMY icon
41
Bristol-Myers Squibb
BMY
$127B
$1.05M 0.45%
16,600
-1,500
-8% -$96.5K
RDS.A
42
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.03M 0.44%
16,100
-500
-3% -$32.9K
BRK.B icon
43
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.03M 0.44%
5,150
-100
-2% -$20.5K
VTI icon
44
Vanguard Total Stock Market ETF
VTI
$654B
$909K 0.39%
6,700
-300
-4% -$42.1K
CELG
45
DELISTED
Celgene Corp
CELG
$899K 0.38%
10,090
+7,315
+264% +$702K
CL icon
46
Colgate-Palmolive
CL
$72.6B
$799K 0.34%
11,122
-35
-0.3% -$2.52K
SLB icon
47
SLB Ltd
SLB
$77.8B
$797K 0.34%
12,303
-4,020
-25% -$281K
STT icon
48
State Street
STT
$50.9B
$753K 0.32%
7,549
-50
-0.7% -$5.24K
UNP icon
49
Union Pacific
UNP
$183B
$752K 0.32%
5,600
-300
-5% -$40.4K
GE icon
50
GE Aerospace
GE
$367B
$671K 0.29%
10,386
-7,504
-42% -$556K
1
2
3

Similar funds

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
LWM
Long Walk Management Greenwich, Connecticut $344M AUM 44.86% 1-Year Est. Return
CWM
Cedar Wealth Management Walnut Creek, California $344M AUM 18.78% 1-Year Est. Return
BA
Ballast Advisors Woodbury, Minnesota $344M AUM 16.81% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
SMG
Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return
FMB
Field & Main Bank Henderson, Kentucky $344M AUM 23.98% 1-Year Est. Return
LKIM
Lawson Kroeker Investment Management Omaha, Nebraska $343M AUM 17.29% 1-Year Est. Return

Michael J. Puzo's Q1 2018 Portfolio in Review

As of Q1 2018, Michael J. Puzo held 80 positions worth $235M, down 3.3% from $243M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 2.5%. Michael J. Puzo opened 1 new position and exited 1, leaving the 80-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Michael J. Puzo's largest Q1 2018 buy was Vertex Pharmaceuticals: 3,000 shares worth $488K.
  • Michael J. Puzo added most to Celgene Corp in Q1 2018, an estimated $702K increase.
  • Michael J. Puzo's biggest Q1 2018 reduction was 3M, cutting an estimated $701K.
  • Michael J. Puzo fully exited Honeywell in Q1 2018, selling an estimated $232K.
  • Michael J. Puzo's ten largest holdings make up 38% of its $235M portfolio in Q1 2018.
  • Michael J. Puzo opened 1 new position and closed 1 in Q1 2018.
  • Michael J. Puzo's portfolio value fell 3.3% quarter-over-quarter to $235M.

Based on Michael J. Puzo's 13F filing for Q1 2018, filed 24 Apr 2018.